SCI Abstract

search
+
Metastatic breast cancer through the Oncotype DX Breast Recurrence Score®: insights from a small cohort study
Metastatic breast cancer through the Oncotype DX Breast Recurrence Score®: insights from a small cohort study
To evaluate the feasibility of obtaining a 21-gene Oncotype DX Breast Recurrence Score® (RS) result from metastatic b...
Genomic and proteomic profiling of mutant metastatic hormone receptor-positive breast cancer and impact on clinical outcomes
Genomic and proteomic profiling of mutant metastatic hormone receptor-positive breast cancer and impact on clinical outcomes
GATA3 mutations are among the most common alterations in hormone receptor-positive (HR+) breast cancer (BC), yet these hav...
Utility of plasma circulating DNA tumor fraction in bone-only metastatic breast cancer: a real-world outcomes study
Utility of plasma circulating DNA tumor fraction in bone-only metastatic breast cancer: a real-world outcomes study
Bone metastases develop in 50–70% of patients with metastatic breast cancer (MBC), with around one-third having bone...
Efficacy and safety of entinostat plus exemestane in hormone receptor-positive breast cancer: a systematic review meta-analysis of randomized controlled trials
Efficacy and safety of entinostat plus exemestane in hormone receptor-positive breast cancer: a systematic review meta-analysis of randomized controlled trials
Hormone receptor-positive (HR+) breast cancer continues to be a significant global challenge, as resistance to endocrine t...
Breast imaging recommendations for young females (age < 40 years) with ≥ 20% lifetime breast cancer risk: practice patterns at a specialized clinic
Breast imaging recommendations for young females (age < 40 years) with ≥ 20% lifetime breast cancer risk: practice patterns at a specialized clinic
The National Comprehensive Cancer Network (NCCN) and American Cancer Society (ACS) endorse differing guidelines for screen...
A mixed-methods study characterizing experiences of medical oncologists’ use of gonadotropin-releasing hormone agonists for treatment of breast cancer
A mixed-methods study characterizing experiences of medical oncologists’ use of gonadotropin-releasing hormone agonists for treatment of breast cancer
The use of ovarian function suppression (OFS) for the treatment of breast cancer in pre-menopausal women is low and little...
National trends in neoadjuvant systemic therapy utilization in patients with early-stage HER2-positive breast cancer from 2016–2021: The impact of the KATHERINE trial
National trends in neoadjuvant systemic therapy utilization in patients with early-stage HER2-positive breast cancer from 2016–2021: The impact of the KATHERINE trial
Neoadjuvant systemic therapy (NST) for HER2 + breast cancer (HER2 + BC) has historically been used...
Insurer and patient costs for repeat breast surgery after initial lumpectomy for breast cancer
Insurer and patient costs for repeat breast surgery after initial lumpectomy for breast cancer
 ~ 14–25% of patients who undergo a primary lumpectomy for the treatment of breast cancer require a reop...
Continuous glucose monitoring to characterize hyperglycemia during chemotherapy for early stage breast cancer
Continuous glucose monitoring to characterize hyperglycemia during chemotherapy for early stage breast cancer
Diabetes (DM) and hyperglycemia during chemotherapy increase the risk of toxicity, yet the prevalence and patterns of hype...
Phase I/II trial investigating gedatolisib plus talazoparib in advanced triple negative or BRCA1/2 positive, HER2 negative breast cancers
Phase I/II trial investigating gedatolisib plus talazoparib in advanced triple negative or BRCA1/2 positive, HER2 negative breast cancers
Metastatic triple negative breast cancer has a poor prognosis with limited targeted treatment options. In preclinical stud...
Tumoral pSMAD2 as a prognostic biomarker in early-stage breast cancer: insights from the randomized SweBCG91RT trial
Tumoral pSMAD2 as a prognostic biomarker in early-stage breast cancer: insights from the randomized SweBCG91RT trial
The TGF-β pathway can influence breast cancer progression and therapy efficacy, exhibiting both pro- and anti-tumoral...
PD-L1 22C3 CPS in paired primary breast cancer and lung metastasis
PD-L1 22C3 CPS in paired primary breast cancer and lung metastasis
This study aimed to evaluate the expression of PD-L1 22C3 in primary breast cancer and lung metastasis tissues using the C...
Neoadjuvant dose-dense anthracycline and cyclophosphamide in combination with carboplatin, paclitaxel, and pembrolizumab for triple-negative breast cancer: a systematic review and meta-analysis
Neoadjuvant dose-dense anthracycline and cyclophosphamide in combination with carboplatin, paclitaxel, and pembrolizumab for triple-negative breast cancer: a systematic review and meta-analysis
Pembrolizumab in combination with chemotherapy has become the standard neoadjuvant regimen for triple-negative breast canc...
Promoting resilience in stress management (PRISM) for patients with early stage breast cancer: a pilot feasibility study
Promoting resilience in stress management (PRISM) for patients with early stage breast cancer: a pilot feasibility study
Women with breast cancer often experience persistent psychological distress. Promoting resilience in stress management (PR...
Mammographic calcifications association with risk of advanced breast cancer
Mammographic calcifications association with risk of advanced breast cancer
Mammographic calcifications on mammograms with a negative/benign assessment are associated with increased breast cancer ri...
Area deprivation index and breast cancer outcomes among patients in Western New York
Area deprivation index and breast cancer outcomes among patients in Western New York
Several studies have shown that residing in regions with high area deprivation index (ADI) is associated with worse outcom...
The effects of contemporary treatment of DCIS on the risk of developing an ipsilateral invasive Breast cancer (iIBC) in the Dutch population
The effects of contemporary treatment of DCIS on the risk of developing an ipsilateral invasive Breast cancer (iIBC) in the Dutch population
To assess the effects of contemporary treatment of ductal carcinoma in situ (DCIS) on the risk of developing an ipsilatera...
Optimizing surgical strategy in locally advanced breast cancer: a comparative analysis between preoperative MRI and postoperative pathology after neoadjuvant chemotherapy
Optimizing surgical strategy in locally advanced breast cancer: a comparative analysis between preoperative MRI and postoperative pathology after neoadjuvant chemotherapy
In the treatment of breast cancer, neo-adjuvant chemotherapy is often used as systemic treatment followed by tumor excisio...
Association of physical weight statuses defined by body mass index (BMI) with molecular subtypes of premenopausal breast cancer: a systematic review and meta-analysis
Association of physical weight statuses defined by body mass index (BMI) with molecular subtypes of premenopausal breast cancer: a systematic review and meta-analysis
The association between overweight/obesity and postmenopausal breast cancer has been proven. However, uncertainty exists r...
Unveiling the HER2-low phenomenon: exploring immunohistochemistry and gene expression to characterise HR-positive HER2-negative early breast cancer
Unveiling the HER2-low phenomenon: exploring immunohistochemistry and gene expression to characterise HR-positive HER2-negative early breast cancer
HER2-low breast cancer (BC) is a novel entity with relevant therapeutic implications, especially in hormone receptor (HR) ...
Interleukin-6 and C-Reactive protein in metastatic breast cancer patients treated with eribulin
Interleukin-6 and C-Reactive protein in metastatic breast cancer patients treated with eribulin
I read with great interest the Bun et al. study [1], in which investigated the association between cytokines and immune ce...
“Enhancing survival outcomes through breast-conserving therapy in ipsilateral breast tumor recurrence: insights into metastasis and treatment strategies”
“Enhancing survival outcomes through breast-conserving therapy in ipsilateral breast tumor recurrence: insights into metastasis and treatment strategies”
We were greatly interested in Qu et al.‘s recent editorial, which discussed the de-escalation of surgery for Ipsilateral B...
Secretory breast carcinoma: clinicopathological features and prognosis of 52 patients
Secretory breast carcinoma: clinicopathological features and prognosis of 52 patients
Secretory breast carcinoma is a rare histological subtype of invasive breast cancer and considered with an indolent clinic...
Percutaneous and intravenous contrast material injection in contrast-enhanced ultrasound for sentinel lymph node evaluation in patients with breast cancer: importance of discussing difference in purposes
Percutaneous and intravenous contrast material injection in contrast-enhanced ultrasound for sentinel lymph node evaluation in patients with breast cancer: importance of discussing difference in purposes
Cite this articleMori, N. Percutaneous and intravenous contrast material injection in contrast-enhanced ultrasound for sen...
A randomized phase II study of metronomic cyclophosphamide and methotrexate (CM) with or without bevacizumab in patients with advanced breast cancer
A randomized phase II study of metronomic cyclophosphamide and methotrexate (CM) with or without bevacizumab in patients with advanced breast cancer
Metronomic chemotherapy has the potential to offer tumor control with reduced toxicity when compared to standard dose chem...
A new methodology to predict the oncotype scores based on clinico-pathological data with similar tumor profiles
A new methodology to predict the oncotype scores based on clinico-pathological data with similar tumor profiles
The Oncotype DX (ODX) test is a commercially available molecular test for breast cancer assay that provides prognostic and...
Superparamagnetic iron oxide (SPIO) for axillary mapping in patients with ductal carcinoma in situ undergoing mastectomy: single-institution experience
Superparamagnetic iron oxide (SPIO) for axillary mapping in patients with ductal carcinoma in situ undergoing mastectomy: single-institution experience
Unnecessary axillary surgery can potentially be avoided in patients with DCIS undergoing mastectomy. Current guidelines re...
The role of endocrine treatment on the risk of developing an ipsilateral invasive breast cancer in hormone receptor positive patients with ductal carcinoma in situ
The role of endocrine treatment on the risk of developing an ipsilateral invasive breast cancer in hormone receptor positive patients with ductal carcinoma in situ
Conflict of interest We declare that I have no conflict of interest...
Presence of crown-like structures in breast adipose tissue; differences between healthy controls, BRCA1/2 gene mutation carriers and breast cancer patients
Presence of crown-like structures in breast adipose tissue; differences between healthy controls, BRCA1/2 gene mutation carriers and breast cancer patients
Crown-like structures (CLS) in breast adipose tissue are associated with inflammation and a potential factor in breast can...
Northern origin of the BRCA2 c.5286 T > G founder allele
Northern origin of the BRCA2 c.5286 T > G founder allele
Conflict of interest The authors declare no conflicts of interest. ...
Load More
format_indent_increase